Alessandra Tebaldi
Impact in
- Infectious Diseases top 10%
- Viral Infections and Vectors
- HIV/AIDS drug development and treatment
- Tuberculosis Research and Epidemiology
Papers in
- Epidemiology 12
- Cytomegalovirus and herpesvirus research 5
- Mycobacterium research and diagnosis 3
- Pneumocystis jirovecii pneumonia detection and treatment 2
- Fungal Infections and Studies 2
-
- Tuberculosis Research and Epidemiology 3
- Co-authors
- Marco Rizzi (3 shared papers)Maria Rosaria Capobianchi (1 shared paper)Giuseppe Ippolito (1 shared paper)C Tosi (1 shared paper)Fredy Suter (2 shared papers)Antonio Goglio (2 shared papers)Fabrizio Carletti (1 shared paper)Carla Nisii (1 shared paper)
In The Last Decade
Alessandra Tebaldi
20 papers receiving 209 citations
Peers
Comparison fields: 5 of 52
- Microbiology 6
- Infectious Diseases 133
- Virology 31
- Parasitology 28
- Applied Microbiology and Biotechnology 6
Countries citing papers authored by Alessandra Tebaldi
This map shows the geographic impact of Alessandra Tebaldi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessandra Tebaldi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessandra Tebaldi more than expected).
Fields of papers citing papers by Alessandra Tebaldi
This network shows the impact of papers produced by Alessandra Tebaldi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessandra Tebaldi. The network helps show where Alessandra Tebaldi may publish in the future.
Co-authors
The 25 scholars most cited alongside Alessandra Tebaldi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 63 | |
| 2 | 1997 | 24 | |
| 3 | 2016 | 21 | |
| 4 | Tolerability of twice-weekly rifabutin-isoniazid combinations versus daily isoniazid for latent tuberculosis in HIV-infected subjects: a pilot study. | 1999 | 20 |
| 5 | 2001 | 20 | |
| 6 | 2021 | 11 | |
| 7 | 2022 | 8 | |
| 8 | 2015 | 7 | |
| 9 | 2019 | 6 | |
| 10 | 1998 | 5 | |
| 11 | 2021 | 5 | |
| 12 | 2018 | 5 | |
| 13 | Tuberculosis due to drug-resistant Mycobacterium bovis in pregnancy. | 1998 | 4 |
| 14 | 2023 | 4 | |
| 15 | 2003 | 3 | |
| 16 | 2024 | 2 | |
| 17 | 1998 | 2 | |
| 18 | 2025 | 1 | |
| 19 | Evaluation of performance of modified sodium lignosulfonate additives as reinforcing agent in porcelain stoneware tiles | 2010 | 1 |
| 20 | 2025 | 1 |
About Alessandra Tebaldi
Alessandra Tebaldi is a scholar working on Epidemiology, Infectious Diseases, Surgery, Small Animals and Virology, having authored 22 papers that have together received 213 indexed citations. Recurring topics across this work include Cytomegalovirus and herpesvirus research (5 papers), HIV Research and Treatment (3 papers), Tuberculosis Research and Epidemiology (3 papers), Mycobacterium research and diagnosis (3 papers), Infectious Diseases and Mycology (3 papers), Pneumocystis jirovecii pneumonia detection and treatment (2 papers), Fungal Infections and Studies (2 papers) and Neonatal Health and Biochemistry (2 papers). The work is most often cited by research in Microbiology (6 citations), Infectious Diseases (133 citations), Virology (31 citations), Parasitology (28 citations) and Applied Microbiology and Biotechnology (6 citations). Alessandra Tebaldi has collaborated with scholars based in Italy, Belgium and Israel. Frequent co-authors include Marco Rizzi, Maria Rosaria Capobianchi, Giuseppe Ippolito, C Tosi, Fredy Suter, Antonio Goglio, Fabrizio Carletti, Carla Nisii, Antonino Di and Concetta Castilletti. Their work appears in journals such as International Journal of STD & AIDS, Emerging infectious diseases, BMC Infectious Diseases, Journal of Medical Virology and Antiviral Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.